AYALA, FABIO
 Distribuzione geografica
Continente #
EU - Europa 2.676
NA - Nord America 1.517
AS - Asia 1.181
SA - Sud America 213
Continente sconosciuto - Info sul continente non disponibili 65
AF - Africa 15
OC - Oceania 2
Totale 5.669
Nazione #
RU - Federazione Russa 1.979
US - Stati Uniti d'America 1.499
SG - Singapore 499
IE - Irlanda 371
HK - Hong Kong 251
CN - Cina 195
BR - Brasile 182
GB - Regno Unito 133
VN - Vietnam 107
DE - Germania 80
KR - Corea 42
FI - Finlandia 31
JP - Giappone 31
IT - Italia 26
AR - Argentina 15
BD - Bangladesh 13
BE - Belgio 11
SE - Svezia 11
CA - Canada 7
IN - India 7
IQ - Iraq 7
ID - Indonesia 6
FR - Francia 5
MX - Messico 5
TR - Turchia 5
AZ - Azerbaigian 4
CL - Cile 4
EC - Ecuador 4
ES - Italia 4
RS - Serbia 4
TN - Tunisia 4
UA - Ucraina 4
AT - Austria 3
EE - Estonia 3
EU - Europa 3
JM - Giamaica 3
NL - Olanda 3
PK - Pakistan 3
UY - Uruguay 3
ZA - Sudafrica 3
BO - Bolivia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AU - Australia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
RE - Reunion 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.608
Città #
Moscow 689
Dublin 371
Chandler 321
Hong Kong 249
Santa Clara 249
Singapore 199
San Jose 135
Ashburn 90
Bremen 59
Cambridge 59
Princeton 59
Roxbury 59
Dallas 56
Beijing 43
Seoul 42
Ho Chi Minh City 39
Council Bluffs 24
Hanoi 23
Des Moines 20
Helsinki 18
Wilmington 18
São Paulo 15
Espoo 13
Munich 13
Ann Arbor 11
Brussels 11
Columbus 9
Belo Horizonte 8
Boston 8
The Dalles 7
Atlanta 6
Los Angeles 6
Milan 6
Shanghai 6
Tokyo 6
Rio de Janeiro 5
Biên Hòa 4
Da Nang 4
Falkenstein 4
Guangzhou 4
Haiphong 4
Stockholm 4
Baku 3
Belgrade 3
Changsha 3
Curitiba 3
Hải Dương 3
London 3
Maceió 3
Manchester 3
Montevideo 3
New York 3
Nha Trang 3
Norwalk 3
Porto Alegre 3
Presidente Prudente 3
Tunis 3
Valparaíso de Goiás 3
Amman 2
Ankara 2
Aracaju 2
Arezzo 2
Bandung 2
Baoding 2
Bexley 2
Brooklyn 2
Campo Grande 2
Can Tho 2
Caratinga 2
Chapecó 2
Chicago 2
Cleveland 2
Clifton 2
Duque de Caxias 2
Fazenda Rio Grande 2
Frankfurt am Main 2
Guarulhos 2
Ha Long 2
Hangzhou 2
Istanbul 2
Itapetinga 2
Johannesburg 2
Joinville 2
Kyiv 2
Lấp Vò 2
Monte Grande 2
Multan 2
Ninh Bình 2
Perugia 2
Petrópolis 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Praia Grande 2
Quảng Ngãi 2
Salvador 2
Santana do Livramento 2
Santiago 2
Secaucus 2
Sete Lagoas 2
Totale 3.108
Nome #
'Eczemas' and leptin 142
Acrodermatitis continua of Hallopeau respondind to efalizumab therapy 141
Abnormal isoaspartyl residues in erythrocyte membranes from psoriasi patients 137
Dermoscopy experts vs dermoscopy non-experts: A comparison between face-to-face diagnosis and telediagnosis for the observation of "pink'' lesions 136
Contact sensitization in the elderly 133
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 129
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 129
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 124
Contact sensitization of older patients in an academic department in Naples 123
Climate change and skin 123
Patch test results with fragrance markers of the baseline series - Analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012 123
Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis 122
Pitfalls in patch testing 119
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 118
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008 118
Development of primary varicella infection during infliximab treatment for psoriasis 118
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 117
Chromatin Assembly Factor-1/p60 overexpression: a potential index of psoriasis severity 117
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 117
Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients 116
Aquagenic wrinkling of the palms: a case report and literature review 109
Effects of climate changes on skin diseases 108
Systemic Treatment of Adult Atopic Dermatitis: A Review 104
Psoriasis in elderly and non elderly population: clinical and molecular features 103
Telediagnosis and face-to-face diagnosis reliability for "pink'' lesions 100
Role of single-immunoglobulin interleukin-1 related receptor (SIGIRR) in psoriasis 94
Psoriasis in melanoma patients: a prospective pilot study 92
Pizza Makers? Contact Dermatitis 91
Erythema multiforme-like eruption because of para-phenylenediamine 87
IL-33 and IL-1F9 in allergic contact dermatitis 87
Systemic Treatment of Pediatric Psoriasis: A Review 87
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? 85
Psoriasis and osteoporosis: data from a Southern Italian population 85
Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi? 85
RAST: Clinical applications 83
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 83
The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis 82
The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members 82
European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014 81
IL-36γ Is Involved in Psoriasis and Allergic Contact Dermatitis 80
Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment 80
Understanding the role of haptoglobin in psoriasis: effects of ultraviolet B 79
IL-26: A new actor in allergic contact dermatitis 78
Psoriatic disease and tuberculosis nowadays 78
IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation 77
Visceral Leishmaniasis Infection in a Patient with Psoriasis Treated with Efalizumab 74
Interleukin-33: increasing role in dermatological conditions 73
Instrument-related Skin Disorders in Musicians 73
Psoriasis in Children: a Review 71
Polymorphic light eruption and innate immunity: the role of interleukin-1 family 70
Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid 69
The European vaseline series in 10 European Countries, 2005/2006 – Results of the European Surveillance System on contact Allergies (ESSCA). Contct Dermatitis 61:31-38, 2009 69
Psoriasis or "psoriases"? 69
Pathogenesis of Psoriasis: The Role of Pro-Inflammatory Cytokines Produced by Keratinocytes 68
IL-33 effects in psoriasis: The induction of pro-inflammatory cytokines via keratinocyte and mast cell activation 67
Psoriasis and Skin Pain: Instrumental and Biological Evaluations 67
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 66
Rational ideation and empiric validation of an innovative digital dermographic tester 66
IL-33 is regulated by TNF-α in normal and psoriatic skin 65
Totale 5.669
Categoria #
all - tutte 23.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022320 0 0 3 0 125 5 6 11 9 5 20 136
2022/2023878 66 43 7 106 114 86 0 50 366 5 21 14
2023/2024239 27 7 8 9 105 0 3 0 2 7 23 48
2024/2025999 0 3 2 47 166 152 133 94 200 86 62 54
2025/20263.056 84 65 165 117 275 1.889 176 39 122 51 45 28
2026/2027118 10 64 44 0 0 0 0 0 0 0 0 0
Totale 5.669